589 Xevinapant plus nivolumab in patients with advanced solid tumors who progressed on prior anti–PD-1/PD-L1 treatment: results of a dose-optimization, exploratory phase 1b/2 trial

Autor:	Emiliano Calvo Aller, Glenn Hanna, Maria Vieito Villar, Caroline Even, Victor Moreno, Chul Kim, Shuchi Gulati, Daniel Morgensztern, Ana Acuna-Villaorduna, Philippe Cassier, Dennie Jones, Florilene Bouisset, Daniela Sahlender, Elisabeth Rouits, Dany Spaggiari, Lars Damstrup, Carlos-Alberto Gomez-Roca
Rok vydání:	2022
Zdroj:	Regular and Young Investigator Award Abstracts.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::2028b5fbd64c167f25d424f7354d7b84 https://doi.org/10.1136/jitc-2022-sitc2022.0589 Zobrazit plný text záznamu